Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
Pharmaceutical / Industry
2-54-52030-156 (408)
NCT00216372
Last Modified:
5/1/1994
2.
Phase II Trial of Somatuline in Patients with Advanced Adenocarcinoma of the Pancreas (Summary Last Modified 05/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
MAOP-5292
NCI-V93-0219
Last Modified:
12/1/1992
3.
Phase I Study of SUR and Somatuline (a Somatostatin Analogue) in Patients with Metastatic Androgen-Resistant Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NCI-91-C-200B
NCI-CPB-274, NCI-T91-0120N, T91-0120
Last Modified:
9/1/1993
4.
Phase I Study of Somatuline to Determine the Biologically Effective Dose in Adolescents and Young Adults with Osteosarcoma (Summary Last Modified 09/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
12 to 30
NCI-93-C-0166
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute